PURPOSE: Most studies of visual development have concentrated on visual development of infants. Only a few studies have extended this to children and determined the point at which visual function becomes truly adult-like. Yet from a clinical and research perspective it is important to know this. This review paper is a discussion of the development of visual acuity and contrast sensitivity into childhood.
METHODS:The literature on subjective (measured with preferential looking or psychophysical methods) and objective (visually-evoked potential) measures of visual acuity and contrast sensitivity was examined with particular emphasis on studies of children over the age of 5 years and those articles that compared different age groups and those that made a comparison with adults. RESULTS: Visual acuity was found to be fully mature between the ages of 5 and the mid teenage years, while contrast sensitivity was found to mature fully between the ages of 8 to 19 years. Thus, there is still no clear answer to the fundamental question of when these basic aspects of visual function mature, but it may be later than previously thought. CONCLUSIONS: Further studies are needed to answer this basic question more precisely and objective measures, such as VEP, may be able to answer this question better than psychophysical methods. KEY WORDS: visual development; visual acuity; contrast sensitivity; critical period; visually-evoked potential. RESUMEN OBJETIVO: La mayoría de los estudios sobre desarrollo visual se han centrado en el desarrollo visual de bebés. Sólo unos pocos estudios han ampliado el intervalo de edades estudiadas para incluir a niños y han determinado en qué momento la función visual alcanza un estado verdaderamente equiparable al de un adulto. Sin embargo, desde una perspectiva clínica y de interés científico, es importante conocer este dato. En este artículo de revisión se analiza el desarrollo de la agudeza visual y de la sensibilidad al contraste a lo largo de la infancia. MÉTODOS: Se analizaron los artículos científicos existentes sobre medidas de agudeza visual y de sensibilidad al contraste, tanto subjetivas (medidas con la técnica de mirada preferencial o por métodos psicofísicos) como objetivas (potenciales visuales evocados), centrándonos particularmente en aquellos estudios realizados en niños mayores de 5 años y en aquellos artículos donde se compararon diversos grupos de edad entre sí o con un grupo de adultos. RESULTADOS: Se encontró que para la agudeza visual el ojo alcanza un estado plenamente maduro a una edad comprendida entre los 5 y los 15-16 años, mientras que para la sensibilidad al contraste el ojo alcanza la madurez plena a una edad comprendida entre los 8 y los 19 años. Así, todavía no disponemos de una respuesta clara a la pregunta fundamental de cuándo estos aspectos de la función visual acaban de madurar, pero es posible que esto suceda a una edad más tardía de la que se creía hasta ahora. CONCLUSIONES: Es necesario realizar más estudios para poder dar una respuesta más precisa a...
This paper discusses the considerations for prescribing a refractive correction in infants and children up to and including school age, with reference to the current literature. The focus is on children who do not have other disorders, for example, binocular vision anomalies, such as strabismus, significant heterophoria or convergence excess. However, refractive amblyogenic factors are discussed, as is prescribing for refractive amblyopia. Based on this discussion, guidelines are proposed, which indicate when to prescribe spectacles and what amount of refractive error should be corrected. It may be argued that these are premature because there are many questions that remain unanswered and we do not have the quality of evidence that we would like; the clinician, however, must make decisions on whether and what to prescribe when examining a child. These guidelines are to aid clinicians in their current clinical decision making.
This is the first comprehensive study of LVS provision by optometrists in Canada. In order for optometrists to become more involved in LVS, there is a need for more LV education, provincial health coverage of optometric LVS, and better collaboration communication between LV providers.
Vision scientists have concentrated on studying two visual functions when it comes to assessing the sensory visual development in human: visual acuity and contrast sensitivity. The methods used to measure these visual functions can be either behavioral or electrophysiological. A relatively new technique for measuring the visual acuity and contrast sensitivity electrophysiologically is the sweep visual evoked potential (sVEP). This paper is a review of the literature on the sVEP technique: stimulus parameters, threshold determination, validity and reliability of sVEP are discussed. Different studies using the sVEP to study the development of visual acuity, contrast sensitivity, and vernier acuity are presented. Studies have demonstrated that the sVEP is a potentially important tool for assessing visual acuity and contrast sensitivity in non-verbal individuals with disorders affecting their visual system.
This study confirms previous findings of a high prevalence of reduced accommodation and shows that near VA is reduced compared to distance VA. The present results indicate that all subjects might benefit from bifocals.
The LEA and HH charts cannot measure a true contrast threshold for children with normal vision because of the floor effect. The LEA symbols at 28 cm gave the most useful information, once recalibrated for contrast, and may be useful to predict performance of children with low vision, when CS is likely to be compromised.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.